Pierre‐Marie Girard

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Chloe Orkin, Keikawus Arastéh, Miguel Górgolas Hernández-Mora et al. · New England Journal of Medicine · 2020 · 427 citations · Full text

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 371 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Week 48 +14

Fanconi syndrome and renal failure induced by tenofovir: A first case report

David Verhelst, Matthieu Monge, Jean‐Luc Meynard et al. · American Journal of Kidney Diseases · 2002 · 354 citations

Renal Failure, Urology, Fanconi Syndrome +1

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

Josep M. Llibre, Chien‐Ching Hung, Cynthia Brinson et al. · The Lancet · 2018 · 338 citations

Treatment And Prevention, Human Retrovirus, Antiviral Therapy +8

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics

Étienne Ruppé, Laurence Armand-Lefèvre, Candice Estellat et al. · Clinical Infectious Diseases · 2015 · 263 citations · Full text